Accelerate Diagnostics Inc
XBER:1A8

Watchlist Manager
Accelerate Diagnostics Inc Logo
Accelerate Diagnostics Inc
XBER:1A8
Watchlist
Price: 6.35 EUR 1.6% Market Closed
Market Cap: €416.6m

Wall St Price Targets

1A8 Price Targets Summary
Accelerate Diagnostics Inc

There are no price targets for 1A8.
Lowest Forecast
Price Target
Not Available
Average Forecast
Price Target
Not Available
Highest Forecast
Price Target
Not Available
Accelerate Diagnostics Inc Competitors:
Price Targets
FDMT
4D Molecular Therapeutics Inc
189% Upside

Revenue
Forecast

20% / Year
Past Growth
7% / Year
Estimated Growth
Estimates Accuracy
-6%
Average Miss
20% / Year
Past Growth
7% / Year
Estimated Growth
Estimates Accuracy
-6%
Average Miss

Over the last 13 years, the compound annual growth rate for Revenue has been 20%. The projected CAGR for the next 1 year is 7%.

Operating Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-2%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-2%
Average Miss

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-78%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-78%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is 1A8's stock price target?
Not Available

1A8 does not have any price targets made by Wall Street professionals.

What is the Revenue forecast for Accelerate Diagnostics Inc?
Projected CAGR
7%

Over the last 13 years, the compound annual growth rate for Revenue has been 20%. The projected CAGR for the next 1 year is 7%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett